<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144479">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01738685</url>
  </required_header>
  <id_info>
    <org_study_id>PRO12050094</org_study_id>
    <nct_id>NCT01738685</nct_id>
  </id_info>
  <brief_title>Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy</brief_title>
  <acronym>Relief</acronym>
  <official_title>Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hormone responsive breast cancer is common and costly. Long-term adjuvant endocrine therapy
      (AET) improves breast cancer outcomes greatly, but, unfortunately, is commonly associated
      with physical and emotional concerns. I propose to evaluate the feasibility and preliminary
      effectiveness of a behavioral intervention to facilitate problem identification, provide
      education, coaching for breast cancer survivors with symptoms while on AET. Therefore, the
      intervention intends to empower women to engage in better self-care and seek out resources
      they need, which, in turn, will lead to better symptom management.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Satisfaction determined by the Client Satisfaction Survey</measure>
    <time_frame>Up to 6 months.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer.</condition>
  <arm_group>
    <arm_group_label>Control.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nutritional Education.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Behavioral Intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Intervention.</intervention_name>
    <arm_group_label>Behavioral Intervention</arm_group_label>
    <other_name>Behavioral Intervention.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Education.</intervention_name>
    <arm_group_label>Control.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 50.

          -  Nonmetastatic bread cancer survivors reporting being bothered by 1 or more symptoms
             related to their treatment with AET (for &gt; 0 months and &lt; 6 months).

          -  Possess a household or cell telephone.

          -  Ability to provide informed consent.

        Exclusion Criteria:

          -  Clinically significant cognitive impairment.

          -  Communication barrier limiting ability to participate in telephone assessments.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G van Londen, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>G van Londen, MD, MS</last_name>
    <phone>4126922382</phone>
    <email>vanLondenJ@upmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>G van Londen, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 27, 2012</lastchanged_date>
  <firstreceived_date>November 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Van Londen, Gijsberta</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer.</keyword>
  <keyword>Adjuvant Endocrine therapy.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
